Single-cell profiling identifies a pro-tumoral VCAN positive macrophage subset and defines a prognostic signature in glioblastoma.
Overview
- Department of Neurology, The First Affiliated Hospital of Yangtze University, Jingzhou First People’s Hospital,Jingzhou, 434000 China
- Graduate student, Yangtze University,Jingzhou, 434000 China
- Department of Neurosurgery, The First Affiliated Hospital of Yangtze University, Jingzhou First People’s Hospital,Jingzhou, 434000 China
- Postgraduate training base Alliance of Wenzhou Medical University,Wenzhou, 325035 Zhejiang China
- Department of Neurosurgery, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences,Hangzhou, 310022 Zhejiang China
- Department of Oncology, The First Affiliated Hospital of Yangtze University, Jingzhou First People’s Hospital,Jingzhou, 434000 China
Abstract
Glioblastoma (GBM), the most aggressive primary brain tumor, develops within a tumor microenvironment (TME) dominated by tumor-associated macrophages (TAMs) that critically influence disease progression. Through single-cell RNA sequencing (scRNA-seq) and bioinformatic analysis, we delineated macrophage heterogeneity within the GBM TME and identified a distinct VCAN⁺ macrophage subpopulation. Pseudotime trajectory analysis revealed these cells at the terminal stage of macrophage differentiation, where they exhibit enhanced granulocyte migration and chemotaxis pathways and exhibit a pro-tumorigenic phenotype that diverges from classical M1/
Supplementary Information: The online version contains supplementary material available at 10.1007/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
No file of the authors' code could be read here: it is described below, and read at its source.
xenabrowser.net/datapages
Availability: 1 check, the latest on 28 September 2026: the link answers (HTTP 200)
- 28 September 2026: the link answers (HTTP 200)
The paper's code and data availability statement is in the Data section.
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 0 scripts, each with its path and the digest of its content;
- no match between paragraphs and code yet;
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
Data links
- ncbi.nlm.nih.gov/
geo , NCBI; found in the text, “Data acquisition and preprocessing”
Data availability
The datasets used and/
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 28 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 10 authors, 5 keywords, 2 funders, 56 references.
Cite
This paper
Guo, J., Zhu, Z., Tong, N., Xu, D., Zhang, H., Lin, C., Wan, G., Wang, Y., Zhou, Q., & Xia, L. (2026). Single-cell profiling identifies a pro-tumoral VCAN positive macrophage subset and defines a prognostic signature in glioblastoma. Discover oncology, 17(1), 969. https://
BibTeX
@article{guo2026single,
author = {Guo, Jiaxin and Zhu, Zhansheng and Tong, Nanyang and Xu, Dingding and Zhang, Huan and Lin, Chenshi and Wan, Guiping and Wang, Yamei and Zhou, Qingqing and Xia, Liang},
title = {{Single-cell profiling identifies a pro-tumoral VCAN positive macrophage subset and defines a prognostic signature in glioblastoma}},
journal = {Discover oncology},
year = {2026},
month = may,
volume = {17},
number = {1},
pages = {969},
publisher = {Springer},
issn = {2730-6011},
doi = {10.1007/
url = {https://
pmid = {42105040},
pmcid = {PMC13323438}
}
RIS
TY - JOUR
AU - Guo, Jiaxin
AU - Zhu, Zhansheng
AU - Tong, Nanyang
AU - Xu, Dingding
AU - Zhang, Huan
AU - Lin, Chenshi
AU - Wan, Guiping
AU - Wang, Yamei
AU - Zhou, Qingqing
AU - Xia, Liang
TI - Single-cell profiling identifies a pro-tumoral VCAN positive macrophage subset and defines a prognostic signature in glioblastoma
T2 - Discover oncology
J2 - Discov Oncol
PY - 2026
DA - 2026/
VL - 17
IS - 1
SP - 969
SN - 2730-6011
PB - Springer
DO - 10.1007/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1007/
"type": "article-journal",
"title": "Single-cell profiling identifies a pro-tumoral VCAN positive macrophage subset and defines a prognostic signature in glioblastoma",
"container-title": "Discover oncology",
"author": [
{
"family": "Guo",
"given": "Jiaxin"
},
{
"family": "Zhu",
"given": "Zhansheng"
},
{
"family": "Tong",
"given": "Nanyang"
},
{
"family": "Xu",
"given": "Dingding"
},
{
"family": "Zhang",
"given": "Huan"
},
{
"family": "Lin",
"given": "Chenshi"
},
{
"family": "Wan",
"given": "Guiping"
},
{
"family": "Wang",
"given": "Yamei"
},
{
"family": "Zhou",
"given": "Qingqing"
},
{
"family": "Xia",
"given": "Liang"
}
],
"container-title-short":
"volume": "17",
"issue": "1",
"page": "969",
"DOI": "10.1007/
"PMID": "42105040",
"PMCID": "PMC13323438",
"ISSN": "2730-6011",
"publisher": "Springer",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
9
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13578-025-01390-1
- Characterization and prognostic of CD8 + TIM3 + CD101 + T cells in glioblastoma multiforme.Journal: Cell & bioscienceIn common: genetics / omics, other condition, 6 references
- [2] doi:10.3390/cancers17111799 [code]
- Identification of an Immune-Related Gene Signature for Prognostic Prediction in Glioblastoma: Insights from Integrated Bulk and Single-Cell RNA Sequencing.Journal: CancersIn common: genetics / omics, other condition, 6 references
- [3] doi:10.3389/fneur.2022.902402
- Construction and validation of a glioblastoma prognostic model based on immune-related genes.Journal: Frontiers in neurologyIn common: other condition, 5 references
- [4] doi:10.3390/biomedicines12030506
- Comprehensive Transcriptomic Profiling of Diverse Brain Tumor Types Uncovers Complex Structures of the Brain Tumor Microenvironment.Journal: BiomedicinesIn common: genetics / omics, other condition, 4 references
- [5] doi:10.1111/jcmm.70814
- Regional Transcriptomic Architecture of Glioblastoma Reveals NUCB2 as a Key Orchestrator of Tumour Aggression and Immune Dysfunction.Journal: Journal of cellular and molecular medicineIn common: genetics / omics, other condition, 3 references
- [6] doi:10.1093/neuonc/noaf113 [code]
- Charting the single-cell and spatial landscape of IDH-wild-type glioblastoma with GBmap.Journal: Neuro-oncologyIn common: genetics / omics, other condition, 3 references
- [7] doi:10.3389/fcell.2024.1396836
- Advancing precision medicine in gliomas through single-cell sequencing: unveiling the complex tumor microenvironment.Journal: Frontiers in cell and developmental biologyIn common: genetics / omics, other condition, 3 references
- [8] doi:10.1111/cpr.13558 [code]
- Integration of human organoids single-cell transcriptomic profiles and human genetics repurposes critical cell type-specific drug targets for severe COVID-19.Journal: Cell proliferationIn common: genetics / omics, other condition, 4 references
- [9] doi:10.1038/s41598-023-31180-z [code]
- Visualizing genomic characteristics across an RNA-Seq based reference landscape of normal and neoplastic brain.Journal: Scientific reportsIn common: genetics / omics, other condition, 4 references
- [10] doi:10.21037/tcr-2025-377
- Single-cell RNA sequencing for characterizing the immune communication and iron metabolism roles in CD31&
lt;sup& gt;+& lt;/ sup& gt; glioma cells. Journal: Translational cancer researchIn common: genetics / omics, other condition, 3 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 0 scripts, and 0 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:9b12c224e48b09f1…
Add the badge to the code's README
If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.
Markdown
<!-- oscr-badge:start -->
[](https://openscicode.org/badge/doi/10.1007/s12672-026-05166-y)
<!-- oscr-badge:end -->reStructuredText
.. oscr-badge:start
.. image:: https://openscicode.org/badge/doi/10.1007/s12672-026-05166-y.svg
:target: https://openscicode.org/badge/doi/10.1007/s12672-026-05166-y
:alt: OSCR
.. oscr-badge:endHTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1007/s12672-026-05166-y"><img src="https://openscicode.org/badge/doi/10.1007/s12672-026-05166-y.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Report a mismatch between the code and the paper · Report a code error (signed in)
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Report a reproduction failure (signed in)
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
